Fmoc-L-Leucine

Fmoc-L-Leucine is an N-(9H-fluoren-9-ylmethoxycarbonyl) protected L-leucine derivative in which the amino group is masked as a stable carbamate while the side chain retains the isobutyl functionality characteristic of leucine. The molecule contains a stereogenic center at the alpha carbon, fixed in the L-configuration, and presents a free carboxylic acid that can be activated for peptide bond formation or converted into alternative C-terminal forms. The Fmoc group undergoes base-mediated removal, enabling orthogonal protection strategies commonly used in iterative solid-phase peptide synthesis, while the unprotected acid and carbamate carbonyl define predictable reactivity under coupling conditions. As a chiral amino acid building block and protected amino acid intermediate, Fmoc-L-Leucine supports downstream synthesis of protected peptides, peptide fragments, and leucine-containing analogs for biochemical and process-oriented workflows.

1. Peptide Synthesis

Fmoc-L-Leucine is used in peptide synthesis workflows where Fmoc protection enables controlled N-terminal deprotection and subsequent coupling cycles. The protected alpha-amino carbamate and the free carboxylic acid allow standard peptide coupling chemistry to form amide bonds while maintaining the L-stereochemistry at the incorporation site. Side-chain isobutyl functionality is chemically inert under typical peptide assembly conditions, minimizing side reactions and supporting clean incorporation into peptide sequences. The resulting leucine-containing peptide building blocks and fragments can be carried into solution-phase or solid-phase assembly for research-grade peptide libraries and sequence-specific constructs.

2. Protected Amino Acids

Fmoc-L-Leucine serves as a protected amino acid building block for orthogonally protected synthesis planning, particularly when both N-protection and C-terminal reactivity must be managed. The Fmoc carbamate provides a base-labile protecting group that can be removed without disturbing acid-sensitive functionalities, while the carboxylic acid can be activated or transformed into derivatives for controlled coupling. The defined chiral center supports stereochemically consistent incorporation into peptides and peptidomimetics, reducing the risk of racemization during downstream transformations. Leucine's hydrophobic side chain can be leveraged to tune peptide solubility, conformation, and binding interfaces in synthetic and biochemical research programs.

3. Bioconjugation Chemistry

Fmoc-L-Leucine is applicable to bioconjugation and chemical biology contexts through leucine-containing peptide handles that can be assembled into functional conjugates. The Fmoc-protected amino acid format supports preparation of peptide motifs bearing reactive termini, such as carboxyl-activated or amine-reactive groups, after Fmoc removal and subsequent derivatization of the peptide backbone. The isobutyl side chain contributes hydrophobic character that can influence conjugate partitioning, surface presentation, and self-association behavior of peptide linkers. Downstream conjugate synthesis can use these leucine-rich linkers to generate stable peptide-based probes, affinity reagents, and modular constructs for biomolecule modification.

4. Process Chemistry Intermediate

Fmoc-L-Leucine functions as a chiral, protected amino acid intermediate for fine chemical synthesis and process chemistry intermediate preparation where reproducible protection-group behavior matters. The Fmoc carbamate and free carboxylic acid define a robust input for scalable peptide building block manufacturing, enabling conversion into activated coupling forms or alternative protected variants for controlled downstream steps. The stereochemical integrity of L-leucine supports consistent product profiles for peptide-grade intermediates that feed into larger synthetic sequences. The compound's compatibility with established Fmoc deprotection and peptide coupling paradigms makes it suitable for industrial manufacturing routes that require predictable handling of protected amino acid units.

5. SAR Studies

Fmoc-L-Leucine is utilized in structure-activity relationship studies where leucine incorporation into peptide analogs and peptidomimetic scaffolds supports systematic exploration of sequence and side-chain effects. The protected amino acid format enables assembly of defined leucine positions within peptide frameworks, supporting comparative evaluation of how hydrophobic isobutyl substitution patterns influence molecular recognition. The Fmoc strategy supports iterative synthesis of analog series with controlled N-terminal presentation and consistent stereochemistry at each incorporated residue. Leucine-containing peptide analogs prepared from Fmoc-L-Leucine can serve as analytical and design intermediates for SAR mapping, fragment optimization, and molecular scaffold refinement in applied medicinal chemistry research.

1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction